Abstract
Aiming at the development of a stable drug carrier for bicalutamide (BT), we prepared various lipid nano-emulsions (LNEs) from a lipid mixture of soybean oil, phosphatidylcholine, sodium palmitate and sucrose palmitate (SP). These LNEs had mean particle size of approximately 50 nm and zeta potential (ζ) of -40 to -30 mV and were investigated their stability in saline solution and in bovine serum by using the dynamic light scattering method. In saline solution, while the droplet size of LNEs without and with BT reached more than 150 nm, that of the BT-encapsulated LNEs with SP could be maintained within 100 nm even after 24 h. In contrast, the droplet size of LNEs hardly increased even over 72 h placed in bovine serum, suggesting that bovine serum albumin (BSA) suppressed their coalescence. The intrinsic fluorescence of BSA was quenched and blue-shifted in the presence of LNE. In addition, the ζ values of all LNEs increased to around -20 mV according to the increase of BSA concentration. These results demonstrated that BSA interacted with LNE particles. Furthermore, the fluorescence resonance energy transfer using a fluorescence probe revealed that not only BT encapsulated in LNE particles but also SP strongly interacted with BSA.
Keywords: Lipid nano-emulsion, bicalutamide, bovine serum albumin, interaction, stability, sucrose palmitate
Current Nanoscience
Title:Effect of Bovine Serum Albumin on the Stability of Bicalutamide-Encapsulated Lipid Nano-Emulsion in Bovine Serum
Volume: 8 Issue: 2
Author(s): Shigehiko Takegami, Shoko Uchida, Eriko Aoi, Takumi Yamamoto, Aki Yasuhara, Madoka Fujihara, Kaori Hayashi and Tatsuya Kitade
Affiliation:
Keywords: Lipid nano-emulsion, bicalutamide, bovine serum albumin, interaction, stability, sucrose palmitate
Abstract: Aiming at the development of a stable drug carrier for bicalutamide (BT), we prepared various lipid nano-emulsions (LNEs) from a lipid mixture of soybean oil, phosphatidylcholine, sodium palmitate and sucrose palmitate (SP). These LNEs had mean particle size of approximately 50 nm and zeta potential (ζ) of -40 to -30 mV and were investigated their stability in saline solution and in bovine serum by using the dynamic light scattering method. In saline solution, while the droplet size of LNEs without and with BT reached more than 150 nm, that of the BT-encapsulated LNEs with SP could be maintained within 100 nm even after 24 h. In contrast, the droplet size of LNEs hardly increased even over 72 h placed in bovine serum, suggesting that bovine serum albumin (BSA) suppressed their coalescence. The intrinsic fluorescence of BSA was quenched and blue-shifted in the presence of LNE. In addition, the ζ values of all LNEs increased to around -20 mV according to the increase of BSA concentration. These results demonstrated that BSA interacted with LNE particles. Furthermore, the fluorescence resonance energy transfer using a fluorescence probe revealed that not only BT encapsulated in LNE particles but also SP strongly interacted with BSA.
Export Options
About this article
Cite this article as:
Takegami Shigehiko, Uchida Shoko, Aoi Eriko, Yamamoto Takumi, Yasuhara Aki, Fujihara Madoka, Hayashi Kaori and Kitade Tatsuya, Effect of Bovine Serum Albumin on the Stability of Bicalutamide-Encapsulated Lipid Nano-Emulsion in Bovine Serum, Current Nanoscience 2012; 8 (2) . https://dx.doi.org/10.2174/157341312800167579
DOI https://dx.doi.org/10.2174/157341312800167579 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Obesity and Cancer: Biological Links and Treatment Implications
Current Cancer Drug Targets (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science Neuroendocrine Tumors of the Lung: Hystological Classification, Diagnosis, Traditional and New Therapeutic Approaches
Current Medicinal Chemistry Current Perspective of Natural Alkaloid Carbazole and its Derivatives as Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target
Current Medicinal Chemistry Adrenomedullin: A Tumor Progression Factor via Angiogenic Control
Current Cancer Drug Targets Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Current Signal Transduction Therapy Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy
Current Radiopharmaceuticals Patent Selections:
Recent Patents on Mechanical Engineering Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Current Cancer Drug Targets Pleiotropic Functions of Rho GTPase Signaling: A Trojan Horse or Achilles Heel for Breast Cancer Treatment?
Current Drug Targets PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery Computerized Tomography (CT) Updates and Challenges in Diagnosis of Bone Metastases During Prostate Cancer
Current Medical Imaging Pharmacogenomics of Xenobiotic Metabolizing Enzymes in South American Populations
Current Pharmacogenomics Ultrashort Echo Time Spectroscopic Imaging: Magnetic Resonance Assessment of Short-T2 Tissues in the Musculoskeletal System
Recent Patents on Medical Imaging Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications.
Current Molecular Medicine Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies
Current Cancer Drug Targets PDGF-D Signaling: A Novel Target in Cancer Therapy
Current Drug Targets